KDR and neoplasm: Contrarily—evaluating the expression profile of αvβ3 integrin, endoglin, and vascular endothelial growth factor receptor 2 (VEGFR2) in subcutaneous breast, ovarian, and pancreatic cancer xenografts—Deshpande et al. published a reverse correlation between tumour size and the presence of angiogenic biomarkers [61].